• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于药物结肠递送的乙基纤维素控释胶囊的制备与评价

Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs.

作者信息

Niwa K, Takaya T, Morimoto T, Takada K

机构信息

Department of Pharmaceutics and Pharmacokinetics, Kyoto Pharmaceutical University, Japan.

出版信息

J Drug Target. 1995;3(2):83-9. doi: 10.3109/10611869509059209.

DOI:10.3109/10611869509059209
PMID:7496731
Abstract

A novel ethylcellulose (EC) capsule which releases drug with a time-controlled fashion has been prepared. This capsule is composed of four parts, drug container, swellable substance, capsule body and cap. At the bottom of the body, micropores are made. As water penetrates through these micropores, the swellable substance such as low substituted hydroxypropyl cellulose (L-HPC) swells. When the cap made of water-insoluble macromolecular substance such as EC cannot persist the swelling pressure, the EC cap disintegrates and the drug in the container is released from the capsule. The lag-time is utilized for the delivery of drug to the colon. The release time of the drug from the capsule was measured both in vitro and in vivo experiments. In the case of an in vitro experiment, after 12mg of fluorescein as a model drug and 238mg of starch were filled into the container, caps having different thickness were attached to the capsule body and release study was performed. The release time of the drug was mainly dependent on the thickness of the cap. Using test capsules of which mean cap thickness were 39.1 +/- 2.3 (SE)microns, 63.1 +/- 5.0 microns and 75.6 +/- 4.1 microns, the in vivo release time was estimated after administration to beagle dogs. As a parameter, the peak time (tmax) when plasma fluorescein concentration reached to its maximum level was determined for the estimation of the release time of the drug from the capsule in the gastrointestinal tract. The in vivo tmax was well correlated with the cap thickness.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

制备了一种能以时间控制方式释放药物的新型乙基纤维素(EC)胶囊。该胶囊由四部分组成,即药物容器、可膨胀物质、胶囊体和胶囊帽。在胶囊体底部制有微孔。当水通过这些微孔渗透时,诸如低取代羟丙基纤维素(L-HPC)之类的可膨胀物质会膨胀。当由诸如EC之类的水不溶性大分子物质制成的胶囊帽无法承受膨胀压力时,EC胶囊帽会崩解,容器中的药物就会从胶囊中释放出来。延迟时间用于将药物输送到结肠。通过体外和体内实验测定了药物从胶囊中的释放时间。在体外实验中,将12mg作为模型药物的荧光素和238mg淀粉装入容器后,将具有不同厚度的胶囊帽连接到胶囊体上并进行释放研究。药物的释放时间主要取决于胶囊帽的厚度。使用平均胶囊帽厚度分别为39.1±2.3(SE)微米、63.1±5.0微米和75.6±4.1微米的测试胶囊,在给比格犬给药后估计其体内释放时间。作为一个参数,测定血浆荧光素浓度达到最高水平时的峰值时间(tmax),以估计药物在胃肠道中从胶囊的释放时间。体内tmax与胶囊帽厚度具有良好的相关性。(摘要截取自250字)

相似文献

1
Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs.用于药物结肠递送的乙基纤维素控释胶囊的制备与评价
J Drug Target. 1995;3(2):83-9. doi: 10.3109/10611869509059209.
2
Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.食物摄入对口服给予比格犬后结肠递送胶囊中作为模型药物的荧光素递送的影响。
J Drug Target. 1996;4(2):59-67. doi: 10.3109/10611869609046263.
3
Development of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in beagle dogs.结肠递送胶囊的研制及重组人粒细胞集落刺激因子(rhG-CSF)在比格犬体内的药理活性
J Pharm Pharmacol. 1995 Jun;47(6):474-8. doi: 10.1111/j.2042-7158.1995.tb05834.x.
4
Technology to obtain sustained release characteristics of drugs after delivered to the colon.将药物递送至结肠后获得药物缓释特性的技术。
J Drug Target. 1999;6(6):439-48. doi: 10.3109/10611869908996850.
5
New preparation method of intestinal pressure-controlled colon delivery capsules by coating machine and evaluation in beagle dogs.采用包衣机的肠压控释结肠给药胶囊新制备方法及在比格犬体内的评价
J Control Release. 1998 Dec 4;56(1-3):293-302. doi: 10.1016/s0168-3659(98)00090-x.
6
Evaluation of an intestinal pressure-controlled colon delivery capsules prepared by a dipping method.采用浸渍法制备的肠道压力控制型结肠递送胶囊的评价
J Control Release. 2001 Apr 2;71(2):175-82. doi: 10.1016/s0168-3659(01)00211-5.
7
[Ulcerative colitis--colon delivery of 5-aminosalicylic acid].[溃疡性结肠炎——5-氨基水杨酸的结肠给药]
Nihon Rinsho. 1998 Mar;56(3):788-94.
8
Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers.含咖啡因作为模型药物的肠道压力控制结肠递送胶囊在人类志愿者中的评估。
J Control Release. 1998 Mar 2;52(1-2):119-29. doi: 10.1016/s0168-3659(97)00201-0.
9
Preparation and evaluation of micro-porous ethylcellulose capsule as oral sustained-release preparation of theophylline.微孔乙基纤维素胶囊作为茶碱口服缓释制剂的制备与评价
Biopharm Drug Dispos. 1998 Jul;19(5):333-9. doi: 10.1002/(sici)1099-081x(199807)19:5<333::aid-bdd109>3.0.co;2-l.
10
Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs.用于结肠给药的乙基纤维素控释胶囊的制备与评价
J Drug Target. 1996;3(6):477-8. doi: 10.3109/10611869609015968.

引用本文的文献

1
Current and future directions of drug delivery for the treatment of mental illnesses.治疗精神疾病的药物输送的当前和未来方向。
Adv Drug Deliv Rev. 2023 Jun;197:114824. doi: 10.1016/j.addr.2023.114824. Epub 2023 Apr 15.
2
Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization.通过用于大规模定制的模块化产品设计概念独立定制剂量和药物释放。
Pharmaceutics. 2020 Aug 14;12(8):771. doi: 10.3390/pharmaceutics12080771.
3
Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.
通过复合制剂增强全噬菌体疗法及其衍生的抗菌酶。
Pharmaceuticals (Basel). 2018 Apr 19;11(2):34. doi: 10.3390/ph11020034.
4
Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil.用于5-氟尿嘧啶结肠靶向的Eudragit S100包衣柑橘果胶纳米颗粒
Materials (Basel). 2015 Feb 27;8(3):832-849. doi: 10.3390/ma8030832.
5
Hollow microspheres for gastroretentive floating- pulsatile drug delivery: preparation and in vitro evaluation.用于胃滞留漂浮-脉冲给药的中空微球:制备与体外评价
Adv Pharm Bull. 2011;1(2):55-61. doi: 10.5681/apb.2011.008. Epub 2011 Dec 15.
6
Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system.用于结肠靶向给药系统的Eudragit S-100包衣萘普生骨架片的制剂及其体外评价
J Adv Pharm Technol Res. 2013 Jan;4(1):31-41. doi: 10.4103/2231-4040.107498.
7
Colon delivery of budesonide: evaluation of chitosan-chondroitin sulfate interpolymer complex.结肠递药:壳聚糖-硫酸软骨素互聚物复合物的评估。
AAPS PharmSciTech. 2010 Mar;11(1):36-45. doi: 10.1208/s12249-009-9353-8. Epub 2009 Dec 17.
8
["Targeted delivery" in the gastrointestinal tract].[胃肠道中的“靶向递送”]
Med Klin (Munich). 1999 Feb 15;94 Suppl 1:6-11. doi: 10.1007/BF03042026.